Evidence map›Paper›PMID 24367669›Full record

ArticlePloS one2013

A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligands.

Dawid Warszycki, Stefan Mordalski, Kurt Kristiansen, Rafał Kafel, Ingebrigt Sylte, Zdzisław Chilmonczyk, Andrzej J Bojarski

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. In Silico Methods for the Discovery of Orthosteric GABAMolecules (Basel, Switzerland) · 2019
    Article
  4. Article
  5. Article
  6. From Homology Models to a Set of Predictive Binding Pockets-a 5-HTJournal of chemical information and modeling · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dawid WarszyckiMedicinal Chemistry Department, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Stefan MordalskiMedicinal Chemistry Department, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Kurt KristiansenMedicinal Pharmacology and Toxicology, Department of Medicinal Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Rafał KafelMedicinal Chemistry Department, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Ingebrigt SylteMedicinal Pharmacology and Toxicology, Department of Medicinal Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Zdzisław ChilmonczykDepartment of Cell Biology, National Medicines Institute, Warsaw, Poland.
Andrzej J BojarskiMedicinal Chemistry Department, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores a new approach to pharmacophore screening involving the use of an optimized linear combination of models instead of a single hypothesis. The implementation and evaluation of the developed methodology are performed for a complete known chemical space of 5-HT1AR ligands (3616 active compounds with K i < 100 nM) acquired from the ChEMBL database. Clusters generated from three different methods were the basis for the individual pharmacophore hypotheses, which were assembled into optimal combinations to maximize the different coefficients, namely, MCC, accuracy and recall, to measure the screening performance. Various factors that influence filtering efficiency, including clustering methods, the composition of test sets (random, the most diverse and cluster population-dependent) and hit mode (the compound must fit at least one or two models from a final combination) were investigated. This method outmatched both single hypothesis and random linear combination approaches.

Indexed as

Cluster AnalysisDrug Evaluation, PreclinicalLigandsModels, MolecularMolecular ConformationReceptor, Serotonin, 5-HT1AReproducibility of ResultsLigandsReceptor, Serotonin, 5-HT1A

Identifiers

PMID24367669
PMCPMC3867515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.